Records 1 - 2
| Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
Breast cancer research and treatment 2012 Jan 131 (2): 653-61.
Hein R, Abbas S, Seibold P, Salazar R, Flesch-Janys D, Chang-Claude
| Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.
American journal of epidemiology 2009 Nov 170 (10): 1241-9.
Reding Kerryn W, Li Christopher I, Weiss Noel S, Chen Chu, Carlson Christopher S, Duggan David, Thummel Kenneth E, Daling Janet R, Malone Kathleen